Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INGENTA PLC Board/Management Information 2018

Oct 31, 2018

7708_rns_2018-10-31_6cc32828-4d3c-49fd-bc0f-400378df64e8.html

Board/Management Information

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7842F

Ingenta PLC

31 October 2018

31 October 2018

Ingenta plc

("Ingenta" or the "Company")

Appointment of Director

Following the Company's announcement dated 3 October 2018, the Company is pleased to confirm that Scott Winner has now been formally appointed to the Board, and makes the following disclosures in accordance with Schedule 2(g) of the AIM Rules for Companies:

Full name (age) Current directorships: Previous directorships / partnerships (over the last five years):
Gregory Scott Winner (50) VISTA Computer Services, LLC.

VISTA North America Holdings, Ltd.

Winner Consultancy
None

As at today's date, Mr Winner holds 20,000 vested options over ordinary shares of 10p each in the capital of the Company. There are no further disclosures to be made in respect of the appointment of Mr Winner.

For further information please contact:

Ingenta plc, Tel: 01865 397 800

Scott Winner, Jon Sheffield

Cenkos Securities plc, Tel: 0207 397 8900

Nicholas Wells, Harry Hargreaves

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

BOALFFLLIILIVIT